Skip to Main Content

Paper Details

Structure-based development of a subtype-selective orexin 1 receptor antagonist.
Proc Natl Acad Sci U S A
25
2020
Author NameAffiliation
Christopher J LangmeadMonash Institute of Pharmaceutical Sciences, Monash University
Peter KolbDepartment of Pharmaceutical Chemistry, Philipps-University Marburg
  • 1 - 2

Datasets

Release 1.2